Avegen vs Sorcero: Revenue, Funding & Team Size Compared
Avegen generates $5.8M in revenue; Sorcero generates $5.9M. Sorcero and Avegen are close to the same size by revenue. The table below compares Avegen and Sorcero on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $5.8M | $5.9M |
| Valuation | Not disclosed | $35.2M |
| Team size | 53 | 57 |
| Founded | 2015 | 2018 |
| HQ | London, United Kingdom | Washington, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Avegen at a glance
Avegen generates $5.8M in revenue with 53 employees, headquartered in London, United Kingdom.
- Revenue
- $5.8M
- Team size
- 53
- Founded
- 2015
Avegen is a digital health platform scale-up. We build digital patient support solutions, digitised clinical workflows and digital therapeutics for our partners. We work with major pharmaceutical companies, research institutes and…
Sorcero at a glance
Sorcero generates $5.9M in revenue with 57 employees, headquartered in Washington, United States.
- Revenue
- $5.9M
- Valuation
- $35.2M
- Team size
- 57
- Founded
- 2018
Mr. Richard Graves is the Chief Impact Officer & a Co-Founder at Ethical Electric. He is the Board Member of Sorcero and Faraday. The founder of Fired Up Media, he served as VP of Project Finance for Solar Mosaic, the Online Organizer for…
Other Avegen alternatives
Avegen competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Avegen vs Sorcero: frequently asked questions
Is Avegen or Sorcero bigger?
Sorcero is the bigger company by revenue, at $5.9M against $5.8M for Avegen.
How much revenue does Avegen make?
Avegen generates $5.8M in annual revenue with a team of 53.
How much revenue does Sorcero make?
Sorcero generates $5.9M in annual revenue with a team of 57.